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ABSTRACT: The interactions between a series of spin-labeled local anesthetic analogues and the nicotinic 
acetylcholine receptor (AChR) have been investigated by means of electron spin resonance (ESR) and 
fluorescence spectroscopy. The paramagnetic local anesthetic analogues quenched the intrinsic tryptophan 
fluorescence of AChR-rich membranes in an agonist-dependent manner, demonstrating a direct interaction 
with the AChR. The quenching efficiency was greater for the benzocaine than for the thioprocaine analogue. 
The protein was found to restrict directly the molecular motion of the spin-labeled analogues, as seen by 
the appearance of a highly anisotropic component in the ESR spectrum. The relative affinity of the population 
of local anesthetic probes which interacts directly with the integral protein of the AChR-rich membranes 
was calculated on the basis of relative association constants, K,, determined by ESR. By comparison with 
the relative association constant for spin-labeled phospholipid, K,,, it was possible to differentiate between 
local anesthetic analogues interacting with high (KJK, ,  > 2), intermediate (KJK, ,  = 1.6-1.9), and low 
(KJK, ,  I 1.3) specificity and to calculate the fraction of protein-associated probe in each case. Differences 
were observed in the presence of agonist (0.1 mM carbamylcholine) with some, but not all, of the spin-labeled 
derivatives. The role of the protonatable diethylammonium group in the specificity of the interaction of 
the procaine and thioprocaine analogues was investigated. Only in the uncharged form, or in the charged 
form a t  high ionic strength, was there a preferential association of these two local anesthetic analogues. 
The specificity of the benzocaine derivative, which lacks the basic side chain, was unaffected by changes 
in pH or ionic strength. 
%e nicotinic acetylcholine receptor (AChR)' from the 
electric organ of Torpedinidae is an integral membrane gly- 
coprotein which recognizes and binds acetylcholine, thereby 
controlling cation permeability of the postsynaptic membrane 
[for a recent review, see Barrantes (1988)l. The AChR in 
the native membrane is located in densely packed regions 
surrounded by a shell of motionally restricted lipids as an 
interface toward other membrane constituents (Marsh & 
Barrantes, 1978; Ellena et al., 1983). Of the aminated and 
quaternary ammonium compounds which interact with AChR 
as agonists or antagonists, aromatic amines are of particular 
interest because these molecules can bind either to low-affinity 
sites at the lipid-protein interface (Lee, 1976) or to discrete 
high-affinity sites at (or near to) the specific cation recognition 
site of the acetylcholine ionophore, thereby regulating channel 
openings (Heidemann et al., 1983). A multiple-site model has 
been elaborated to explain the positive cooperativity of non- 
competitive antagonists such as local anesthetics and his- 
trionicotoxin on the conformational transitions of AChR (Sine 
& Taylor, 1982). 
Spin-label electron spin resonance (ESR) spectroscopy has 
an inherent time scale optimally suited to resolving the spectra 
of freely tumbling small molecules in the aqueous phase from 
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those in the fluid bilayer regions of the membrane and of lipids 
in the latter environment from those motionally restricted at 
the intramembranous surface or bound to integral membrane 
proteins [for a review, see Marsh (1985)l. Thus, the ESR 
spectra of spin-labeled local anesthetics provide a most useful 
method for studying the molecular details of lipid-local an- 
esthetic-protein interaction in receptor-rich membranes. The 
synthesis of spin-labeled intracaine2 has been reported by 
' Abbreviations: AChR, nicotinic acetylcholine receptor; EDTA, 
ethylenediaminetetraacetic acid; ESR, electron spin resonance; Hepes, 
N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid. 
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Gargiulo et al. (1973), and two classes of association sites have 
been identified by Earnest et al. (1984); the motionally re- 
stricted component observed in the presence of carbamyl- 
choline chloride has been assigned to molecules at the high- 
affinity allosteric site of the acetylcholine ionophore (Palma 
et al., 1985). The charge state of the protonatable diethyl- 
ammonium group has been correlated to the anesthetic potency 
(Blickenstaff & Wang, 1985). 
Here we have examined the interaction of local anesthetics 
in AChR-rich membrane vesicles from Torpedo marmorata, 
making use of the designed series of spin-labeled local an- 
esthetic analogues shown in Chart I (Hideg et al., 1979). The 
effects of partitioning between the aqueous and membrane 
phases and motional restriction at the intramembranous 
surface of the integral protein in the AChR-rich membranes 
have been separated, and it is shown that a certain population 
of the local anesthetics are in contact with the AChR in a 
manner similar to that of fatty acids and phospholipids. The 
role of desensitization and amine or quaternary charge has 
been investigated in an attempt to obtain a coherent picture 
of the structure and function relationships. 
Biochemistry, Vol. 29, No. 37, 1990 
MATERIALS AND METHODS 
Materials. N-[3H]Propionyl-a-bungar~toxin (sp act. 107 
Ci/mmol) was from Amersham International PLC (Amers- 
ham, U.K.); Percoll and Sephadex G-25 were from Pharmacia 
Fine Chemicals (Uppsala, Sweden). Unlabeled benzocaine, 
procaine, and tetracaine were from Sigma (St. Louis, MO). 
Spin-labeled local anesthetic analogues I-IV (see Chart I) were 
synthesized as described in Hideg et al. (1979). The other 
spin-label derivatives, V-X (see Chart I), were synthesized 
by analogous methods, and their detailed characterization will 
be reported elsewhere. All other reagents were of the highest 
purity available. 
Purification of AChR-Rich Membrane Vesicles. T.  mar- 
morata specimens from the Bay of Arcachon, France, were 
generously provided by Prof. V. Whittaker (Max-Planck-In- 
stitut fur biophysikalische Chemie) and maintained in aquaria 
until use. A crude membrane pellet from homogenized electric 
organs was prepared according to the method of Lindstrom 
et al. (1980), and membrane vesicles enriched in AChR were 
obtained by discontinuous sucrose gradient centrifugation as 
described by Elliot et al. (1980). Sealed and leaky vesicles 
were further fractionated by the method of Sachs et al. (1982) 
by exchange of Na+ within the vesicles for external Cs+ and 
by subsequent separation on the basis of density on a Per- 
coll-CsCI gradient. The specific a-bungarotoxin binding 
activity, assayed by the method of Schmidt and Raftery 
(1973), was typically 1.1-2.4 nmol of 3H-labeled a-bungaro- 
toxin/mg of protein. Protein determination was performed 
according to the method of Lowry et al. (1951) with bovine 
serum albumin as standard. In all ESR and fluorescence 
quenching experiments the sealed vesicle fraction was used as 
the native membrane. 
ESR Experiments. Sealed membrane vesicles were cen- 
trifuged in  an Eppendorf centrifuge for 15 min at full speed 
in order to remove the remaining CsC1-Percoll, and the 
floating layer was washed in 10 mM sodium phosphate, pH 
7.4, or 10 mM Hepes, pH 8.0. The resuspended pellet in 1-mL 
final volume (0.3-0.6 mg of protein, corresponding to ca. 0.5 
pM AChR) was labeled with 20 pg of spin-labeled local an- 
Horvith et al. 
2-[N-Methyl-N-(2,2,6,6-tetramethyl- 1 -oxyl-4-piperidiny1)aminol- 
ethyl 4-(hexy1oxy)benzoate and 2-[N,N-dimethyl-N-(2,2,6,6-tetra- 
methyl-I -oxyl-4-piperidinyl)amino]ethyl4-(hexyloxy)benzoate, which are 
the nitroxide-labeled tertiary and quaternary analogues of intracaine, 
respectively (Earnest, 1984; Palma et al., 1985). 
esthetics (concentration range: 46 pM for I11 to 64 pM for 
I) previously dissolved in absolute ethanol (2% of the total 
volume) and allowed to interact at room temperature for 45 
min. Then the vesicles were centrifuged at  45 000 rpm in a 
Beckman 50 Ti rotor for 45 min, and the pellet was transferred 
into ESR sample capillaries (I-mm i.d.) and concentrated in 
a bench-top centrifuge. To minimize the aqueous signal, the 
samples were trimmed to IO-" height by carefully removing 
excess vesicle suspension and supernatant. The estimated 
spin-label/AChR ratio was 15 mol/mol in the membrane, 
assuming a partition coefficient of 10. 
ESR spectra were recorded with a Varian E-1 2 Century line 
spectrometer equipped with a nitrogen gas flow temperature 
regulation system. Temperatures were measured to fO. 1 OC 
with a thermocouple placed just above the cavity within the 
sample capillary. ESR spectra were collected on an IBM 
personal computer with Labmaster interface (12 bit A/D 
resolution) using software written by Dr. M. D. King (Max- 
Planck-Institut fur biophysikalische Chemie) and stored as 
1-kword data files. Spectral subtractions were performed with 
a VT- 11 interactive graphic display processor (Digital 
Equipment Co.) using software written by Dr. W. Moller 
(Max-Planck-Institut fur biophysikalische Chemie). 
Fluorescence Measurements. Membrane fragments (80-90 
nM a-bungarotoxin binding sites, 55-60 pg of protein/mL) 
were suspended in 1 mL of IO mM sodium phosphate buffer, 
pH 8.0, by brief sonication (2 min) and incubated with 1-25 
pg of spin-labeled local anesthetics (previously dissolved in 5 
pL of ethanol) at room temperature for 70 min. The effect 
of agonist was measured in parallel experiments. Carba- 
mylcholine chloride (0.1 mM) was allowed to react with 
AChR-rich membranes for 50 min prior to the addition of local 
anesthetic (desensitized state) or added simultaneously with 
the local anesthetic and incubated for 70 min. The vesicle 
suspensions were placed in 1 X 1 cm quartz cuvettes, and the 
intrinsic fluorescence of the protein was recorded as the total 
spectrum above 320 nm (Schott WG-320 filter) with an SLM 
spectrofluorometer using Xe-Hg arc excitation at 296 nm (200 
W). In order to correct for inner-filter effects, the absorption 
of the procaine thioester (111) and benzocaine (I) spin-labels 
at the excitation and emission wavelengths was measured in 
buffer alone. The static absorption factor, I, used to correct 
the apparent quenching is given by 
log I = -Aex(Lex/2) [cI/ [cexl - Aem(Lem/2) [cI/ [ceml (1 ) 
where [c] is the concentration of spin-labeled local anesthetic 
probe used in the fluorescence quenching experiments, [c,,] 
and [c,,] are the concentrations used to determine the ab- 
sorption at  excitation (Aex) and emission (Aem) wavelengths, 
respectively, and Le, and Le, are the respective path lengths 
along the excitation and emission axes. 
RESULTS 
A typical ESR 
spectrum of the spin-labeled analogue of procaine thioester 
(compound 111) in native membranes from T.  marmorata is 
shown in Figure 1A. The spectrum is dominated by the 
extremely narrow peaks from the proportion of the spin-labeled 
molecules remaining in the aqueous phase. The contribution 
of this aqueous spectral component to the integrated intensity 
is small; from quantitative double integration, a fraction of 
8% was obtained for compound I11 (Figure IA), and the 
fraction varied between 8% and 32% for the other spin-labeled 
local anesthetic analogues (see faq values in Table I). By 
comparison of the ESR spectra obtained in the native mem- 
brane and in aqueous dispersions of the extracted lipids 
Assignment of Spectral Components. 
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FIGURE 1: Spectral subtractions with a typical ESR spectrum of 
compound I11 (spin-labeled analogue of procaine thioester): (A) 
AChR-rich membranes from T. marmorafu; (B) aqueous component 
(downscaled); (C) lipid-associated component; (D) protein-associated 
component. Spectra C and D were obtained by subtracting the 
aqueous signal from the spectra of the pH-dependence series (Figure 
5 )  and resolving the two membrane-associated components by in- 
tersubtractions between these difference spectra. The lower spectrum 
is shown together with a simulated slow-motion line shape (dotted 
line), which was used in all subsequent spectral subtractions. Con- 
centrations are given under Materials and Methods. Total scan width 
= 100 G; T = 22 OC. 
Table I :  Lipid/Water Partitioning, fsq, and Relative Association 
Constant, KJK,, of Spin-Labeled Local Anesthetic Analogues in 
Acetylcholine Receptor Rich Membranes from T. murmorufa" 
AG - AGO 
compd J;. f KJK, (kJ/mol) 
111 (procaine thioester) 0.08 0.34 2.2 -1.9 
I (benzocaine) 0.11 0.35 2.3 -2.0 
V 0.12 0.31 1.9 -1.6 
VI 0.12 0.27 1.6 -1.1 
IX 0.18 0.36 2.4 -2.1 
VI+/Me 0.21 0.31 1.9 -1.6 
I 1  (procaine) 0.22 0.23 1.3 -0.6 
X (tetracaine) 0.23 0.31 1.9 -1.6 
VI11 0.30 0.28 1.7 -1.2 
IV (procainamide) 0.32 0.29 1.7 -1.4 
"fa is the fraction of spin-labeled compound in the aqueous phase. 
A vahe  of f, = 0.19, corresponding to spin-labeled phosphatidyl- 
choline. was used in calculatina K J K ,  (cf. ea 2). 
(spectrum not shown), the presence of a third spectral com- 
ponent was evident in the outer wings of the membrane spectra. 
The two membrane-associated spectral components could be 
resolved by subsequent pairwise intersubtractions with mem- 
brane spectra containing different proportions of these two 
components, as illustrated in Figure 1 .  The sharp spikes in 
spectra C and D arise from slight mismatches in the sub- 
traction of the aqueous component and do not contribute 
appreciably to the total integrated spectral intensity. 
The two spectral components, which were observed in both 
native membranes and dispersions of the extracted lipids, were 
00 01  02 
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FIGURE 2: Modified Stern-Volmer plots of the quenching of the 
intrinsic protein fluorescence in AChR-rich membranes (80-90 nM 
a-bungarotoxin binding sites) by spin-labeled analogues of (A) procaine 
thioester (111) and (B) benzocaine (I). Fluorescence quenching, after 
70-min incubation of spin-labeled drug, with AChR membranes 
pretreated for 50 min with carbamylcholine chloride (A) or with AChR 
membranes in the presence (0) or absence (0) of 0.1 mM carba- 
mylcholine. 
Table 11: Apparent Quenching Constant, KQ, and Apparent Fraction 
of Available Fluorophores, fa, for Quenching by Spin-Labeled Local 
Anesthetic Analogues in AChR-Rich Membranes" 
spin-label carbamylcholine Kp (M-I) f a  
111 (procaine thioester) none 1.8 X lo5 0.40 
coincubation 5.0 X IO4 0.51 
preincubation 1.1 X los 0.44 
coincubation 1.8 X lo' 0.99 
preincubation 4.5 X IO4 0.65 
"The apparent parameters were determined from the linear region of 
the modified Stern-Volmer plot (Figure 2), wheref, = l/intercept and 
KQ = intercept/slope. The slope was determined by linear regression, 
and the correlation coefficient was at least 0.989. The AChR was in 
the resting, coincubated, and desensitized states, corresponding to no 
incubation, coincubation, and preincubation with carbamylcholine, re- 
spectively. 
I (benzocaine) none 3.3 x 104 0.67 
assigned to spin-labeled anesthetics partitioning between the 
aqueous and fluid lipid phases (spectra B and C in Figure 1). 
The third component was observed only in the native mem- 
branes and, therefore, was assigned to anesthetic molecules 
undergoing restricted motion at  the lipid-protein interface 
(spectrum D in Figure 1). This assignment is consistent with 
previous ESR results obtained with spin-labeled fatty acids, 
phospholipids, and steroids, which have also been interpreted 
in terms of populations in the fluid bilayer and at  the interface 
of intrinsic membrane proteins (Marsh & Barrantes, 1978; 
Marsh et al., 1981; Ellena et al., 1983). The protein-associated 
component was analyzed quantitatively by a second spectral 
subtraction, and as expected, the quality of these ESR dif- 
ference spectra depended critically on the purity of the dif- 
ference spectrum from the first subtraction used to remove 
the aqueous component. The protein-associated component 
displayed a spectral anisotropy and line shape typical for slow 
motion (2A,,, = 63.7 G a t  22 "C) and could be simulated 
with the modified Bloch equations (dotted line in Figure 1D; 
Horvfith et al., 1988). 
Local Anesthetic-Protein Interaction from Fluorescence 
Quenching. Evidence for the contact interaction of spin-labeled 
local anesthetic analogues with the interface of the AChR was 
obtained from quenching the intrinsic protein fluorescence by 
the paramagnetic local anesthetics [cf. Marsh and Barrantes 
(1978)l. The aromatic chromophores of the AChR represent 
a heterogeneous population with varying quenching constants, 
and the apparent fraction of available fluorophores (fa) and 
their apparent quenching constant (KQ) were obtained from 
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FIGURE 3: Representative ESR spectra of various spin-labeled an- 
esthetics in AChR-rich membrane vesicles from T. marmorata, after 
subtracting the aqueous spectral component. Concentrations used 
are given under Materials and Methods. All spectra were recorded 
at 22 OC; scan width = 100 G. Small residual aqueous peaks seen 
in several of the difference spectra, principally in the high-field region, 
have a contribution of <OS% to the total integrated spectral intensity. 
The molecular structures of compounds I-IX are given in Chart I. 
the modified Stern-Volmer plot (Lehrer, 1971). These results 
are given in Figure 2 and Table 11. 
Drug Specificity. A series of ESR spectra of the various 
spin-labeled anesthetics in AChR-rich membranes, which was 
obtained after subtraction of the various aqueous components, 
is shown in Figure 3. Small residual aqueous peaks are seen 
in some of these subtraction end points, mostly in the high-field 
region, which arise because of difficulties in exactly matching 
the line widths of the extremely sharp aqueous spectra. 
However, the contribution of these spurious peaks to the total 
integrated spectral intensity is less than 0.5% and therefore 
can be neglected. The fractions of motionally restricted 
component were quantitated by subtraction of the simulated 
spectrum of the protein-associated component (dotted line in 
Figure 1 D) from these difference spectra. The quantitative 
data obtained from the two stages of spectral subtraction are 
summarized in Table I. The fraction of spin-labeled anesthetic 
partitioning into the aqueous phase is given byf,,, and the 
fraction of the membrane-associated spin-labeled anesthetic 
which is motionally restricted by interaction with the intrinsic 
membrane protein is given by$ It should be noted that each 
spectrum recorded with the different spin-labeled anesthetics 
could be described with the above three components; the 
combined intensity determined for these components by 
Table 111. Fractions of Protein-Associated Component, f, and 
Relative Association Constants, KJK,,  of Spin-Labeled Local 
Anesthetic Analogues after Various Treatments of AChR-Rich 
Membranes" 
AG - AGO 
spin-label treatment f Kr/Kro (kJ/mol) 
I11 none 0.35 2.3 -2.0 
I11 carbamylcholine chloride 0.34 2.2 -1.9 
I none 0.32 2.0 -1.7 
I carbamylcholine chloride 0.31 1.9 -1.6 
I1 none 0.25 1.4 -0.9 
111 pH 6 0.34 2.2 -1.9 
111 pH 9 0.44 3.4 -3.0 
I PH 6 0.33 2.1 -1.8 
-1 .o 
I1 p H 9  0.31 1.9 -1.6 
I11 <0.01 M NaCl 0.34 2.2 -1.9 
I11 1 M NaCl 0.39 2.1 -2.5 
I <0.01 M NaCl 0.30 1.8 -1.5 
I 1 M NaCl 0.31 1.9 -1.6 
11 carbamylcholine chloride 0.22 1.2 -0.5 
I PH 9 0.35 2.3 -2.0 
0.26 1 .5  I1 p H 6  
"A value of fo = 0.19, corresponding to spin-labeled phosphatidyl- 
choline, was used in calculating KJK.. (cf. eq 2) .  
spectral addition agreed with the total spectral intensity to 
within 5%. 
The relative contribution of the aqueous component depends 
on the lipid/water partitioning of the different spin-labeled 
anesthetics and is seen to increase gradually on going from 
compounds 111, I, VI, and V to compounds IV and VI11 (Table 
I). The second spectral subtraction, performed on the mem- 
brane-associated spectra, furnishes information on the relative 
association constants of the different spin-labeled anesthetics 
with the protein (Table I). Assuming that the different drugs 
compete with lipids for sites at the protein interface, one can 
obtain the relative association constants, K,, from the fractions 
of protein-associated spin-label, f,, compared with the value, 
f,, for a nonselective phospholipid [see, e.g., Marsh (1985)l: 
These relative association constants and the differential free 
energies of association AG - AGO = -RT In (KJK,) are given 
in Table I. A value offo = 0.19, corresponding to the fraction 
of motionally restricted spin-labeled phosphatidylcholine [a 
nonspecific phospholipid; cf. Ellena et al. (1983)l determined 
in the same membrane preparations, was used as a reference 
in Table I. On the basis of the relative association constants, 
the spin-labeled anesthetics can be divided roughly into three 
groups as follows: high-specificity drugs, such as compounds 
111, I, and IX ( K J K , ,  > 2); medium-specificity drugs, such 
as compounds IV-VI, VI+/Me (the quaternized salt of VI), 
VIII, and X (KJK,, = 1.6-1.9); low-specificity drug, such 
as compound I1 (Kr/Kr, = 1.3). 
Allosteric Interaction and Drug Competition. The allosteric 
interaction between the binding sites for agonists and local 
anesthetics was studied by comparing the fractions of the 
protein-associated component for three different spin-labeled 
local anesthetics, I1 (spin-labeled procaine analogue), 111 
(spin-labeled procaine thioester analogue), and I (spin-labeled 
benzocaine analogue), before and after coincubation of the 
membranes with 0.1 mM carbamylcholine chloride (Figure 
4). Of the three spin-labeled molecules tested, the motionally 
restricted component of compound I1 decreased, whereas that 
of compounds 111 and I remained essentially unchanged. The 
relative association constants are given in Table 111. 
The competition of compound 111 (spin-labeled procaine 
thioester analogue) with unlabeled procaine, tetracaine, and 
benzocaine was followed by measuring the fraction of pro- 
Kr/Kro [(I -fo)/foI/[(l -fx)/fxl ( 2 )  
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FIGURE 4: Effect of carbamylcholine chloride on the ESR spectra 
of spin-labeled analogues of procaine and benzocaine in AChR-rich 
membranes. The overlaid spectra were recorded with (dotted line) 
and without (full line) the addition of 0.1 mM carbamylcholine 
chloride. (A) Compound 111 (spin-labeled analogue of procaine 
thioester); (B) compound I (spin-labeled analogue of benzocaine); 
(C) compound 11 (spin-labeled analogue of procaine). Membrane 
and spin-label concentrations are given under Materials and Methods. 
Total scan width = 100 G: T = 22 'C. 
tein-associated spin-label component, with drug/spin-label 
ratios of 1 and 10 mol/mol. No significant displacement of 
the spin-labeled local anesthetics was observed as estimated 
from the fraction of the protein-associated component, after 
addition of the unlabeled drugs at up to 10-fold excess (data 
not shown). 
Dependence on p H  and Ionic Strength. The possible role 
of the protonatable diethylammonium group in local anes- 
thetic-protein interaction was studied by recording ESR 
spectra at pH 6 and 9, corresponding to the positively charged 
and uncharged forms, respectively (Figure 5 ) .  Of the three 
compounds chosen for these experiments, the fractions of the 
protein-associated component significantly increased in the case 
of compounds I1 and 111 (spin-labeled procaine and procaine 
thioester analogues) in their uncharged forms, whereas com- 
pound I (spin-labeled benzocaine analogue) was virtually 
unaffected, consistent with the lack of a protonatable group 
in this molecule. The relative association constants at the two 
pHs are given in  Table 111. No such trend could be distin- 
guished, however, in a comparison of compound VI and its 
quaternized salt VI+/Me (Table I). 
In another series of experiments the effect of high mono- 
valent salt concentration on drug-protein interaction was in- 
vestigated with the charged form of the procaine thioester 
analogue (111) with the uncharged benzocaine analogue (I) 
as control (Figure 6 and Table 111). An increase in the fraction 
of protein-associated component was observed for compound 
111 at high ionic strength: the fraction increased from 0.34 
to 0.40 with an increase of the salt concentration from 0 to 
1 M NaCI, while the ESR spectrum of compound I remained 
unchanged. 
DISCUSSION 
A series of spin-labeled analogues of local anesthetics has 
been used to investigate the interaction with the AChR protein 
A 
FIGURE 5: Influence of pH on the ESR spectra of spin-labeled local 
anesthetics in AChR-rich membranes. Each pair was recorded at 
pH 6 (full line) and at pH 9 (dotted line). (A) Compound 111 
(spin-labeled analogue of procaine thioester); (B) compound I 
(spin-labeled analogue of benzocaine); (C) compound I1 (spin-labeled 
analogue of procaine). Concentrations are given under Materials and 
Methods. Total scan width = 100 G; T = 22 'C. 
" I f  
FIGURE 6: ESR spectra of spin-labeled local anesthetic analogues in 
AChR-rich membranes, as a function of NaCl concentration. Each 
pair was recorded in <0.01 M NaCl (full line) and in 1 M NaCl 
(dotted line). (A) Compound 111 (spin-labeled analogue of procaine 
thioester); (B) compound I (spin-labeled analogue of benzocaine). 
Membrane and spin-label concentrations are given under Materials 
and Methods. Total scan width = 100 G; T = 22 'C. 
in its native membrane environment. Moderately low spin- 
labeled probe to lipid ratios were used (ca 1:25 mol/mol), thus 
minimizing possible fluidizing effects associated with higher 
anesthetic concentrations (Boulanger et al., 1981). A common 
feature in the ESR spectra of all spin-labeled local anesthetic 
analogues in the AChR-containing membranes was the 
presence of two components. One component is attributed to 
probe in the bulk lipid bilayer and the other to the perturbation 
of the probe mobility in the motionally restricted environment 
at the interface with the AChR and other integral proteins 
in the membrane (cf. Figures 1 and 3). Previous work using 
spin-labeled intracaine and its quaternary analogue2 also 
demonstrated motionally restricted spectra in both reconsti- 
8712 
tuted (Earnest et al., 1984) and AChR-enriched membranes 
(Palma et al., 1985, 1986). On the basis of the quantitative 
parameters summarized in Table I, it is possible to compare 
the apparent degree of association of the different spin-labeled 
local anesthetics with the integral protein of the AChR 
membrane. 
The titration behavior of the local 
anesthetic-protein interaction with pH is of special interest 
in view of the marked differences, both in steady-state phar- 
macological effects and in rates of action, between aminated 
local anesthetics in their uncharged deprotonated forms and 
the cationic protonated species. The latter are preferentially 
confined to the aqueous phase; their accessibility to the ex- 
citable membrane is lower, and their rate of action is slower 
than that of the corresponding uncharged form (Hille, 1977). 
The aminated local anesthetic analogues used here are weak 
bases; the pK of the spin-labeled intracaine derivative,2 for 
instance, has been found to be 7.2-7.4 (Wang et al., 1983). 
The interfacial contributions to the pK of tetracaine have also 
been analyzed, and similar conclusions were reached with 
regard to the pK in neutral micelles (Garcia-Soto & 
Fernlndez, 1983). Thus at  the physiological pH used in most 
of the experiments here, the ESR spectra from the spin-labeled 
local anesthetic analogues will represent the sum of the con- 
tributions from the charged and uncharged species [cf. Lim- 
bacher et al. (1985)l. 
The results of the pH titration of the spin-labeled local 
anesthetic analogues demonstrate that the local anesthetic- 
protein interaction is strongly dependent on the state of pro- 
tonation of the probe. A clear pH dependence was observed 
for compounds I1 and 111 (procaine analogue and its thioester 
derivative). In contrast, no pH dependence was observed for 
the benzocaine derivative, I, which does not bear a protonatable 
group (see Figure 5 and Table III) ,  confirming that the pH 
dependence for compounds I1 and 111 arises from titration of 
the local anesthetic analogue and not of the protein or another 
membrane constituent. A similar lack of sensitivity to pH has 
been observed with the permanently charged, quaternary 
derivative of methylated tetracaine (Limbacher et al., 1985; 
Earnest et al., 1984). 
The finding that the specificity of interaction with the 
protein is greater in the unprotonated than in the protonated 
(positively charged) form for the procaine ester (11) and 
thioester (111) derivatives correlates, in electrostatic terms, with 
the specificity found of the AChR for negatively charged lipids 
(Ellena et a]., 1983). However, it is not in accord with the 
results of Earnest et al. ( I  984), who observed that a greater 
proportion of the positively charged form of a spin-labeled 
intracaine derivative2 is motionally restricted than of the un- 
charged form. In these latter studies it was also found that 
the cationic form of the spin-label had a higher potency than 
the neutral species in inhibiting the ion-flux response of 
AChR-containing liposomes (Blikenstaff & Wang, 1985). It 
will be noted that, also in the present studies, a higher pro- 
portion of the fully charged, quaternary compound VI+/Me 
is associated with the protein than of the incompletely pro- 
tonated analogue, VI, at  pH 7.4 (see Table I). 
Ionic Strength Dependence. Increasing salt concentration 
caused a screening of the electrostatic interactions between 
the protein and the spin-labeled procaine thioester (111) de- 
rivative giving rise to an increase in the relative association 
constant (Figure 6 and Table H I ) .  This change in apparent 
affinity is consistent with the increase observed on titration 
from pH 6.0 to pH 9.0, Le., to the deprotonated (uncharged) 
state (cf. Table 111). No salt dependence was observed in the 
Biochemistry, Vol. 29, No. 37, 1990 
pH Dependence. 
HorvPth et al. 
case of the neutral benzocaine derivative, confirming the effects 
of electrostatic interactions on the affinity in the case of the 
charged derivatives. It will be noted that the neutral local 
anesthetic analogues show a considerable degree of affinity 
for the protein, relative to the zwitterionic phospholipid 
phosphatidylcholine. 
Effects of Agonists. The apparent affinity for the protein 
of the spin-label derivatives was found not to change very 
greatly in the presence of carbamylcholine (see Table 111). 
Only for derivative I1 (procaine analogue) was there a small 
change in the presence of agonist. In the case of an intracaine 
spin-label,2 a high-affinity binding site was observed for ESR 
in the presence of agonist (Palma et al., 1985, 1986). The 
apparently small degree of allosteric regulation by cholinergic 
agonist may well be due to the diluting effect of additional 
association of the spin-labeled anesthetics with integral proteins 
other than the AChR. 
Fluorescence Quenching Experiments. The amino acid 
sequence of the AChR from Torpedo contains more than 50 
Trp and 80 Tyr residues (Noda et al., 1983). The former 
dominate the fluorescence of the protein and, according to 
current models [see Barrantes (1988)], are predominantly 
located in the extramembranous domain of the AChR. In fact, 
in both the four-chain (Noda et al., 1983; Claudio et al., 1983) 
and the five-chain (Finer-Moore & Stroud, 1984) receptor 
models, only one Trp residue is postulated to occur in the 
bilayer region and hence to be a likely target for paramagnetic 
quenching by the spin-labeled local anesthetic analogues. 
Comparison of the quenching efficiency between compounds 
I and 111 demonstrates that the fluorophores in native AChR 
membranes are quenched 1.7-fold more efficiently by the 
benzocaine than by the procaine thioester spin-labeled ana- 
logue. 
Receptor activation is a multistep process that may involve 
a transient intermediate state in which agonist binds at  a 
low-affinity site and doubly liganded AChRs fully open a 
cation-selective channel. On prolonged exposure to agonist, 
the average number of open channels decreases, and the re- 
ceptor affinity increases, reaching the thermodynamically 
favored desensitized state. The similarity between the 
quenching values for the native and agonist-incubated states 
(Table 11) indicates that the majority of the AChR channels 
are unable to reach a transiently activated state in the presence 
of the local anesthetic analogue. However, the quenching 
efficiency for compounds I and 111 differed in the presence 
of agonist (Figure 2 and Table II), suggesting that the spin- 
labeled analogues sense two different states of AChR or, al- 
ternatively, bind to two sites differing in affinity. 
128632-14-4; V, 128632-1 5-5; VI, 98647-68-8; VI/Me, 128632-20-2; 
19-9; acetylcholine, 51-84-3. 
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Association of a pH-Sensitive Peptide with Membrane Vesicles: Role of Amino 
Acid Sequence+ 
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ABSTRACT: The solution properties and bilayer association of two synthetic 30 amino acid peptides, GALA 
and LAGA, have been investigated at  pH 5 and 7.5. These peptides have the same amino acid composition 
and differ only in the positioning of glutamic acid and leucine residues which together compose 47% of each 
peptide. Both peptides undergo a similar coil to helix transition as the pH is lowered from 7.5 to 5.0. However, 
GALA forms an amphipathic a-helix whereas LAGA does not. As a result, GALA partitions into membranes 
to a greater extent than LAGA and can initiate leakage of vesicle contents and membrane fusion which 
LAGA cannot (Subbarao et al., 1987; Parente et al., 1988). Membrane association of the peptides has 
been studied in detail with large phosphatidylcholine vesicles. Direct binding measurements show a strong 
association of the peptide GALA to vesicles at pH 5 with an apparent K, around lo6. The single tryptophan 
residue in each peptide can be exploited to probe peptide motion and positioning within lipid bilayers. 
Anisotropy changes and the quenching of tryptophan fluorescence by brominated lipids in the presence of 
vesicles also indicate that GALA can interact with uncharged vesicles in a pH-dependent manner. By 
comparison to the peptide LAGA, the membrane association of GALA is shown to be due to the amphipathic 
nature of its a-helical conformation at  pH 5 .  
L o w  
ployed 
molecular weight synthetic peptides have been em- 
to unravel the role of amino acid seauence in the 
synthetic peptides are being used as simplified models of li- 
Domoteins. membrane channels. or fusogenic moteins in an . .  
function of membrane-interactive protein segAents. These 
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attempt to relate peptide conformation, ogentation in the lipid 
bilayer, and supramolecular structure to their function (Spach 
et al., 1989; Lear et al., 1988). 
One of our main objectives was to investigate the role of 
hydrophobicity and secondary structure, especially the am- 
phipathic a-helix, in defining the interaction of proteins with 
membranes. We designed a peptide using predictive algor- 
ithms governing hydrophobicity (Kyte & Doolittle, 1982; 
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macy, University of California. 
versity, Evanston, IL 60201. 
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